课题基金 / 基金详情

Translational Neuroscience Core

Translational Neuroscience Core
转化神经科学核心
批准号:
8846265
负责人:
Mary E Blue
金额:
$14.81万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Mary E Blue的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of the Translational Neuroscience Core (Core D) is to provide the best expertise possible to the analysis of preclinical (animal and human) models of disorders that lead to intellectual and other developmental disabilities, and to the analysis of relevant clinical samples. Another primary goal of this Translational Neuroscience Core is to facilitate the transfer of basic discoveries to clinical trials. To achieve these objectives. Core D has scientists with expertise in modeling developmental disorders in animals and experts who can perform assays that are not available elsewhere and that can unravel the biochemical/metabolic mechanisms that cause intellectual disability. For many of the studies, investigators utilizing the Translational Neuroscience Core are interested in visualizing effects on the brain. One of the major functions of Core D is to provide training and access to the Histology and Preclinical Imaging Facilities. Another major function is to provide a group of highly specialized assays that target metabolites and molecules of relevance to intellectual and developmental disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted Therapies for Rett Syndrome
  • 批准号:
    9811146
  • 项目类别:
  • 资助金额:
    $43.48万
  • 财政年份:
    2019
  • 负责人:
    Mary E Blue
  • 依托单位:
Targeted Therapies for Rett Syndrome
  • 批准号:
    9916821
  • 项目类别:
  • 资助金额:
    $40.59万
  • 财政年份:
    2019
  • 负责人:
    Mary E Blue
  • 依托单位:
Dendrimer therapies for treatment of Rett Syndrome
  • 批准号:
    9334327
  • 项目类别:
  • 资助金额:
    $20.39万
  • 财政年份:
    2016
  • 负责人:
    Mary E Blue
  • 依托单位:
Dendrimer therapies for treatment of Rett Syndrome
  • 批准号:
    9235088
  • 项目类别:
  • 资助金额:
    $26.0万
  • 财政年份:
    2016
  • 负责人:
    Mary E Blue
  • 依托单位:
海外基金